Statement
Medical Devices Regulation
Statement
AESGP Statement on Regulation (EU) 2024/1860 amending the IVDR and MDR
Medical Devices Regulation
Statement
AESGP Statement on the European Commission’s legislative proposal amending the IVDR and MDR
Shortages
Statement
WINTER IS COMING: AESGP reassures that a wide range of Self-Care options are available for the cold season
Pharma Law
Press release
Statement
EU Pharma Legislation Review: A unique opportunity to strengthen health systems for the benefit of all
Medical Devices
Medical Devices Regulation
Statement
AESGP welcomes MDR amendment and highlights need to tackle MDR systemic issues
Medical Devices
Medical Devices Regulation
Statement
Statement on European Commission’s legislative proposal amending the MDR
Environment
Press release
Statement
Joint Statement on the Urban Waste Water Treatment Directive (UWWTD) Proposal
Energy
Statement
Ukraine
Statement on the European Commission’s Communication “Save gas for a safe winter”
Medical Devices
Medical Devices Regulation
Statement
Statement on the MDCG Guidance on borderline between medical devices and medicinal products under Regulation (EU) 2017/745 on medical devices (MDCG 2022 – 5)
Medical Devices
Medical Devices Regulation
Statement
Statement on the Medical Devices Regulation's date of application
Health Data
Statement
European Stakeholder Group Statement - Maintaining the exchange of critical health data
Cancer
Self-care
Statement
Reaction to European Beating Cancer Plan
Environment
Press release
Statement
European Pharmaceutical Industry Statement on the Update on the Progress and Implementation of the EU Strategic Approach to Pharmaceuticals in the Environment
OTC
Pharma Strategy
Self-care
Statement
Reaction to European Commission’s Communication on the EU Pharmaceutical Strategy
Brexit
Statement
Joint EU-UK pharmaceutical industry response to Specialised Committee outcome
Statement
EU Health Coalition: 10 recommendations to build a stronger EU Health Union
Environment
Statement
EU Pharma Industry's joint statement on the European Parliament’s Resolution on Pharmaceuticals in the Environment
COVID-19
Self-care
Shortages
Statement
Remarks on EU4Health Programme
Brexit
Statement
Joint Letter on the Need for a Mutual Recognition Agreement between the EU and UK
OTC
Self-care
Statement
Reaction to European Commission’s Roadmap on the Pharmaceutical Strategy
Food supplements
OTC
Self-care
Statement
Reaction to European Commission’s Farm to Fork Strategy release
COVID-19
Statement
EU Health Coalition calls for more solidarity and coordinated EU action to tackle COVID-19
Brexit
Press release
Statement
Pharma industry calls for Mutual Recognition on GMP between EU and UK
Self-care
Shortages
Statement